← Back to headlines
Summit Therapeutics Reports Q4 Earnings, Missing EPS Estimates
Summit Therapeutics announced its fourth-quarter financial results, with Non-GAAP EPS of -$0.14, missing estimates by $0.12.
23 Feb, 21:40 — 23 Feb, 21:40
Sources
Showing 1 of 1 sources
Related Stories
BASF Files Patent Infringement Lawsuit Against Apple Over Face Authentication Tech
11m ago
Adobe Appoints Anil Chakravarthy as Chief Executive Officer Amid Leadership Transition
14m ago
Volkswagen Announces Plan to Cut 100,000 Jobs by 2030
32m ago
Vice President Vance Downplays Iran Conflict, Declines to Label It a War
45m ago